Most active Nasdaq-traded stocks
AP - Wed Dec 24, 5:02PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), ARCP: 8.33 (unch), MSFT: 48.14 (-0.31), INTC: 37.44 (+0.01), AAPL: 112.01 (-0.53), CSCO: 28.30 (+0.05)
Nasdaq stocks posting largest percentage increases
AP - Wed Dec 24, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
KNDI: 12.90 (+0.99), WATT: 9.46 (+1.49), ACHN: 13.06 (+1.22), PLMT: 18.77 (+2.03)
February 2015 Options Now Available For Achillion Pharmaceuticals
at The Street - Wed Dec 24, 11:30AM CST
Investors in Achillion Pharmaceuticals Inc. saw new options begin trading today, for the February 2015 expiration.
ACHN: 13.06 (+1.22)
Biotech Stock Roundup: AbbVie's HCV Treatment Approved, ImmunoGen Plunges on Data - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Dec 24, 8:48AM CST
Will Express Scripts' announcement regarding AbbVie's (ABBV) Viekira Pak lead to a pricing war in the hepatitis C virus (HCV) market?
BIIB: 340.89 (+5.13), VRTX: 115.15 (+1.40), CBST: 100.29 (-0.09), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), IMGN: 5.90 (+0.13), ABBV: 66.21 (+1.86)
Premarket Gainers / Losers as of 9:10 ET
Seeking Alpha - at Seeking Alpha - Wed Dec 24, 8:12AM CST
NVGS: 20.00 (+2.10), ACHN: 13.06 (+1.22), ADMS: 16.10 (+1.45), DGLY: 15.62 (+0.82)
The Hepatitis C Drug Developer That Crushed Gilead Sciences, Inc. in 2014 (Hint: It's Not AbbVie)
Sean Williams, The Motley Fool - Motley Fool - Wed Dec 24, 8:03AM CST
For shareholders of Gilead Sciences it's practically been a dream year . Shares rose close to 40%, tacking on roughly $45 billion in market value, following the successful approval and launch of oral hepatitis C drugs Sovaldi and Harvoni. ...
JNJ: 104.59 (+0.31), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), ABBV: 66.21 (+1.86), BMY: 59.15 (-0.01), ENTA: 49.04 (+0.06)
Achillion set for gap up at the open
Seeking Alpha - at Seeking Alpha - Wed Dec 24, 8:01AM CST
ACHN: 13.06 (+1.22)
Achillion Gains on Positive Results from its HCV Candidates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 4:00PM CST
Achillion Pharmaceuticals (ACHN) gained more than 9% after announcing encouraging results from its HCV candidates.
JNJ: 104.59 (+0.31), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), AMGN: 160.67 (+3.15)
Hertz and Green Mountain are big market movers
AP - Tue Dec 23, 3:53PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
NBL: 48.50 (-0.48), BB.TO: 12.41 (-0.17), HTZ: 24.38 (-0.09), GMCR: 137.65 (+1.10), OCN: 14.88 (-0.14), NBR: 12.42 (-0.26), VNDA: 14.69 (+1.11), BBRY: 10.67 (-0.13), DRL: 3.38 (-0.02), BZH: 18.59 (+0.03), ENTA: 49.04 (+0.06), BA: 131.24 (+1.21), CELG: 109.60 (+3.48), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), CHK: 19.84 (-0.45), TASR: 26.86 (+0.84)
Dow Reaches Record Close as Santa Claus Rally Hits Day 5
at The Street - Tue Dec 23, 3:04PM CST
The Dow Jones Industrial Average breaks through 18,000 on Tuesday as third-quarter GDP shows signs of better-than-expected economic health.
PSX: 72.10 (-0.46), HTZ: 24.38 (-0.09), GMCR: 137.65 (+1.10), OCN: 14.88 (-0.14), XOM: 93.78 (-0.81), NQ: 4.32 (-0.36), XLV: 68.64 (+0.50), AGO: 26.28 (+0.23), ESRX: 85.48 (-0.40), RDN: 16.78 (+0.18), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), CHK: 19.84 (-0.45), ABBV: 66.21 (+1.86), CVX: 113.47 (-0.48), SWN: 28.46 (-0.46), WAG: 76.67 (+0.16), REGN: 400.12 (+6.07), XLE: 80.13 (-0.59)
Why Achillion Pharmaceuticals Shares Collapsed by 25% Today
Todd Campbell, The Motley Fool - Motley Fool - Tue Dec 23, 2:03PM CST
Source: Achillion Pharmaceuticals What's happening? Shares of Achillion Pharmaceuticals are crashing 25% today after the company reported mixed early stage drug trial results yesterday and following Express Scripts ' decision to remove ...
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), ABBV: 66.21 (+1.86)
Dow, S&P 500 Near Session Highs After GDP Growth Smashes Expectations
at The Street - Tue Dec 23, 1:25PM CST
The Dow Jones Industrial Average breaks through 18,000 on Tuesday as third-quarter GDP shows signs of better-than-expected economic health.
GPRO: 66.41 (+4.87), GMCR: 137.65 (+1.10), OCN: 14.88 (-0.14), NQ: 4.32 (-0.36), XLV: 68.64 (+0.50), AGO: 26.28 (+0.23), ESRX: 85.48 (-0.40), RDN: 16.78 (+0.18), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), CHK: 19.84 (-0.45), ABBV: 66.21 (+1.86), SWN: 28.46 (-0.46), WAG: 76.67 (+0.16), REGN: 400.12 (+6.07)
Midday Gainers /Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 11:45AM CST
NICK: 14.80 (+0.20), JRJC: 5.81 (-0.11), OCN: 14.88 (-0.14), ZAZA: 3.20 (+0.70), VNDA: 14.69 (+1.11), EPAX: 2.46 (-0.08), FES: 1.19 (-0.01), NQ: 4.32 (-0.36), TECU: 3.59 (-0.14), VRML: 1.81 (+0.15), MYOS: 7.10 (+0.07), PME: 2.00 (+0.10), ESPR: 35.97 (-0.08), ALNY: 93.52 (+0.97), IDSA: 4.52 (-0.18), PRLS: 6.85 (+0.01), ACHN: 13.06 (+1.22), SKYS: 11.05 (-0.95), RCPT: 122.05 (+4.05), AGIO: 109.67 (+2.45)
Dow Industrials Top 18,000 but Biopharma Stocks Drag Nasdaq Lower
at The Street - Tue Dec 23, 10:29AM CST
The Dow Jones Industrial Average breaks through 18,000 on Tuesday as stock markets gain.
AVP: 9.22 (-0.07), GMCR: 137.65 (+1.10), NQ: 4.32 (-0.36), SBUX: 81.27 (-0.16), AGO: 26.28 (+0.23), ESRX: 85.48 (-0.40), RDN: 16.78 (+0.18), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), CHK: 19.84 (-0.45), ABBV: 66.21 (+1.86), SWN: 28.46 (-0.46), WAG: 76.67 (+0.16), REGN: 400.12 (+6.07)
AbbVie HCV competitors getting slapped in early trading
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 9:49AM CST
GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), ABBV: 66.21 (+1.86)